pharma
-
Franchise India Bureau Dec 10 2018 - 1 min readDrug firm AstraZeneca Pharma India has inked a distribution agreement with Abbott Healthcare to distribute a diabetes medicine 'Dapagliflozin' in India. Dapagliflozin, an innovative Type 2 diabetes medicine, is a leading diabetes medicine of AstraZeneca Pharma. AstraZeneca Pharma said, "Under the agreement, Abbott will promote and distribute Dapagliflozin under the brand name GLEDEPA. Abbott will also gain the ...
-
Franchise India Bureau Oct 17 2018 - 1 min readThe Haryana government will establish a pharma park over 100 acres of land in Karnal. Apart from this, Haryana Pharmaceutical Policy 2018 is being framed to facilitate pharmaceutical companies in the state. The aim of framing this policy is to simplify the working of pharma companies and provide maximum employment to youth in the state. Vipul ...
-
Franchise India Bureau Oct 12 2018 - 1 min readUttar Pradesh government is in talks with several multinational companies and domestic players for setting up six pharma parks across the state. The state government has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies like Mylan, GE, Pfizer and Sanofi. Sidharth Nath Singh, Uttar Pradesh Health Minister, said, ...
-
Franchise India Bureau Oct 04 2018 - 0 min readThe government has relaxed import norms for about 34 chemicals used in the pharmaceuticals industry. The move would ease inbound shipments of these items. These chemicals include cocaine, norephedrine, cathine and its salts, ephedrine hydrochloride and concentrates of poppy straw, nicotinic acid and aminorex. The Directorate General of Foreign Trade (DGFT) said, "The import policy of ...
-
Agencies Sep 29 2017 - 2 min readThe Maharashtra Food and Drug Administration (FDA) has cancelled licenses of 2,241 retail pharmacies and suspended licenses of another 1,857 retailers across the state for violation of Drugs & Cosmetics (D&C) Act like dispensing medicines without prescription. The move was taken up as a follow-up of show cause notices issued by FDA to 4,503 ...
